SALEM, N.H.--(BUSINESS WIRE)--Gamma Medica, developer of advanced digital molecular imaging technologies for the detection of breast cancer, announced today that it has formed a strategic advisory board comprised of distinguished clinicians and thought leaders with expertise in women’s health technologies and diagnostic imaging. Robert Cascella, former chief executive officer of Hologic, will chair the strategic advisory board. The board will provide strategic and operational counsel as Gamma Medica continues the development and commercialization of its LumaGEM® Molecular Breast Imaging system.
Help employers find you! Check out all the jobs and post your resume.
